Literature DB >> 16765724

The panorama of cerebral palsy after very and extremely preterm birth: evidence and challenges.

Michael E Msall1.   

Abstract

During the past 2 decades, major advances in maternal-fetal medicine and neonatology have resulted in unprecedented survival of very preterm (<32 weeks) and extremely preterm (<28 weeks) babies. Despites these advances in prenatal care, neurodevelopmental motor impairment remains a substantial sequela. This article describes the major progress and challenges in understanding pathways of preterm children who go on to have one of the cerebral palsy syndromes. The contributions of chronic lung disease, intraventricular hemorrhage, retinopathy of prematurity, and postnatal steroids are analyzed. Management can then be directed to limiting the comorbidities that are associated with threats to survival and to improving protection of central nervous system functions that are involved in moving, manipulative skills, feeding, communication, and learning.

Entities:  

Mesh:

Year:  2006        PMID: 16765724     DOI: 10.1016/j.clp.2006.03.012

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  7 in total

1.  Histologic chorioamnionitis and acute neurologic impairment in premature infants.

Authors:  Sanjiv B Amin; Hongyue Wang
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

2.  Cerebral palsy among term and postterm births.

Authors:  Dag Moster; Allen J Wilcox; Stein Emil Vollset; Trond Markestad; Rolv Terje Lie
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

3.  Early prediction of cerebral palsy after neonatal intensive care using motor development trajectories in infancy.

Authors:  Nathalie L Maitre; James C Slaughter; Judy L Aschner
Journal:  Early Hum Dev       Date:  2013-07-12       Impact factor: 2.079

Review 4.  Noninvasive autoregulation monitoring with and without intracranial pressure in the naive piglet brain.

Authors:  Ken M Brady; Jennifer O Mytar; Kathleen K Kibler; Charles W Hogue; Jennifer K Lee; Marek Czosnyka; Peter Smielewski; R Blaine Easley
Journal:  Anesth Analg       Date:  2010-06-02       Impact factor: 5.108

5.  Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: An individual participant data meta-analysis.

Authors:  Caroline A Crowther; Philippa F Middleton; Merryn Voysey; Lisa Askie; Sasha Zhang; Tanya K Martlow; Fariba Aghajafari; Elizabeth V Asztalos; Peter Brocklehurst; Sourabh Dutta; Thomas J Garite; Debra A Guinn; Mikko Hallman; Pollyanna Hardy; Men-Jean Lee; Kimberley Maurel; Premasish Mazumder; Cindy McEvoy; Kellie E Murphy; Outi M Peltoniemi; Elizabeth A Thom; Ronald J Wapner; Lex W Doyle
Journal:  PLoS Med       Date:  2019-04-12       Impact factor: 11.069

6.  Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity".

Authors:  Sidney A Schechet; Sarah Hilkert Rodriguez; Michael J Shapiro; Michael P Blair
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

7.  Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol.

Authors:  Caroline A Crowther; Fariba Aghajafari; Lisa M Askie; Elizabeth V Asztalos; Peter Brocklehurst; Tanya K Bubner; Lex W Doyle; Sourabh Dutta; Thomas J Garite; Debra A Guinn; Mikko Hallman; Mary E Hannah; Pollyanna Hardy; Kimberly Maurel; Premasish Mazumder; Cindy McEvoy; Philippa F Middleton; Kellie E Murphy; Outi M Peltoniemi; Dawn Peters; Lisa Sullivan; Elizabeth A Thom; Merryn Voysey; Ronald J Wapner; Lisa Yelland; Sasha Zhang
Journal:  Syst Rev       Date:  2012-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.